The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?

被引：1
|
作者：
Seifert, Robert [1 ,2 ]
Eiber, Matthias [3 ,4 ]
Herrmann, Ken [1 ,2 ]
Hadaschik, Boris [2 ,5 ]
Fendler, Wolfgang Peter [1 ,2 ,6 ]
机构：
[1] Univ Duisburg Essen, Dept Nucl Med, Hufelandstr 55, D-45147 Essen, Germany
[2] Univ Hosp Essen, German Canc Consortium DKTK, Hufelandstr 55, D-45147 Essen, Germany
[3] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Munich, Germany
[4] Bavarian Canc Res Ctr BZKF, Munich, Germany
[5] Univ Duisburg Essen, Dept Urol, Essen, Germany
[6] German Soc Nucl Med, PET Comm, Gottingen, Germany
来源：
CLINICAL AND TRANSLATIONAL IMAGING | 2024年 / 12卷 / 01期
关键词：
D O I：
10.1007/s40336-023-00596-y
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [1] The novel PROMISE framework for PSMA-PET reporting: ready for the clinical routine?
    Robert Seifert
    Matthias Eiber
    Ken Herrmann
    Boris Hadaschik
    Wolfgang Peter Fendler
    Clinical and Translational Imaging, 2024, 12 (1) : 1 - 3
  • [2] The Updated Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE V2.0) Framework for Standardized Reporting of PSMA-PET
    Seifert, R.
    Emmett, L.
    Herrmann, K.
    Hadaschik, B.
    Calais, J.
    Fanti, S.
    Hope, T. A.
    Hofman, M. S.
    Eiber, M.
    Fendler, W. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S177 - S177
  • [3] Prognostic PSMA-PET PROMISE nomograms for patients with prostate cancer
    Fendler, Wolfgang Peter
    Karpinski, Madeleine J.
    Huesing, Johannes
    Claassen, Kevin
    Moeller, Lennart
    Kajueter, Hiltraud
    Oesterling, Florian
    Gruenwald, Viktor
    Umutlu, Lale
    Lanzafame, Helena
    Telli, Tugce
    Merkel-Jens, Anja
    Huesing, Anika
    Kesch, Claudia
    Herrmann, Ken
    Stang, Andreas
    Hadaschik, Boris A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Lymph node classification in E-PSMA reporting guidelines for PSMA-PET
    Evyn G. Arnfield
    Matthew J. Roberts
    David A. Pattison
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 50 : 8 - 9
  • [5] Lymph node classification in E-PSMA reporting guidelines for PSMA-PET
    Oprea-Lager, Daniela E.
    Ceci, Francesco
    Eiber, Matthias
    Fanti, Stefano
    Herrmann, Ken
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 50 (01) : 10 - 11
  • [6] E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
    Ceci, Francesco
    Oprea-Lager, Daniela E.
    Emmett, Louise
    Adam, Judit A.
    Bomanji, Jamshed
    Czernin, Johannes
    Eiber, Matthias
    Haberkorn, Uwe
    Hofman, Michael S.
    Hope, Thomas A.
    Kumar, Rakesh
    Rowe, Steven P.
    Schwarzenboeck, Sarah M.
    Fanti, Stefano
    Herrmann, Ken
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (05) : 1626 - 1638
  • [7] E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
    Francesco Ceci
    Daniela E. Oprea-Lager
    Louise Emmett
    Judit A. Adam
    Jamshed Bomanji
    Johannes Czernin
    Matthias Eiber
    Uwe Haberkorn
    Michael S. Hofman
    Thomas A. Hope
    Rakesh Kumar
    Steven P. Rowe
    Sarah M. Schwarzenboeck
    Stefano Fanti
    Ken Herrmann
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1626 - 1638
  • [8] Use of PROMISE criteria on PSMA-PET for prediction of overall survival in prostate cancer
    Bouchelouche, Kirsten
    Choyke, Peter L.
    LANCET ONCOLOGY, 2024, 25 (09): : 1107 - 1108
  • [9] PSMA-PET and PROMISE re-define stage and risk in prostate cancer patients
    Karpinski, M.
    Huesing, J.
    Claassen, K.
    Moeller, L.
    Kajueter, H.
    Oesterling, F.
    Gruenwald, V.
    Umutlu, L.
    Lanzafame, H.
    Telli, T.
    Merkel-Jens, A.
    Huesing, A.
    Kesch, C.
    Herrmann, K.
    Stang, A.
    Hadaschik, B.
    Fendler, W. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S194 - S195
  • [10] PSMA-PET and PROMISE re-define stage and risk in patients with prostate cancer
    Fendler, W. P.
    Karpinski, M.
    Huesing, J.
    Claassen, K.
    Kajueter, H.
    Oesterling, F.
    Gruenwald, V.
    Umutlu, L.
    Telli, T.
    Merkel-Jens, A.
    Huesing, A.
    Kesch, C.
    Hoberueck, S.
    Meyer, P.
    Kind, F.
    Rahbar, K.
    Schaefers, M.
    Stang, A.
    Herrmann, K.
    Hadaschik, B. A.
    ANNALS OF ONCOLOGY, 2024, 35 : S971 - S971
12345